CircZBTB46, a promising therapeutic target in crizotinib resistant ALK-positive T lymphomas
Loélia Babin, Elissa Andraos, Steffen Fuchs, Chloe Bessière, Lola Colras, Sandra Dailhau, Cathy Quelen, Cindy Pinto, Iyad Daoudi, Romain Pfeifer, Ahmed Zamani, Marina Bousquet, Stéphane Pyronnet, Christine Gaspin, Laurence Lamant, Fabienne Meggetto
juin 2026